Ceribell Stock Net Income
| CBLL Stock | 22.31 0.38 1.67% |
As of the 24th of January, CeriBell shows the Risk Adjusted Performance of 0.2041, mean deviation of 2.68, and Downside Deviation of 2.76. CeriBell technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CeriBell treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if CeriBell is priced correctly, providing market reflects its regular price of 22.31 per share. Given that CeriBell has jensen alpha of 0.8343, we suggest you to validate CeriBell's prevailing market performance to make sure the company can sustain itself at a future point.
CeriBell Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 8.3819 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -36.4 M | -38.2 M | |
| Net Loss | -36.4 M | -38.2 M | |
| Net Loss | (3.89) | (4.09) | |
| Net Income Per E B T | 0.90 | 0.80 |
CeriBell | Net Income | Build AI portfolio with CeriBell Stock |
Latest CeriBell's Net Income Growth Pattern
Below is the plot of the Net Income of CeriBell over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in CeriBell financial statement analysis. It represents the amount of money remaining after all of CeriBell operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is CeriBell's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CeriBell's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (40.45 M) | 10 Years Trend |
|
Net Income |
| Timeline |
CeriBell Net Income Regression Statistics
| Arithmetic Mean | (36,922,969) | |
| Coefficient Of Variation | (5.70) | |
| Mean Deviation | 937,934 | |
| Median | (37,164,000) | |
| Standard Deviation | 2,104,142 | |
| Sample Variance | 4.4T | |
| Range | 11M | |
| R-Value | 0.09 | |
| Mean Square Error | 4.7T | |
| R-Squared | 0.01 | |
| Significance | 0.73 | |
| Slope | 38,009 | |
| Total Sum of Squares | 70.8T |
CeriBell Net Income History
Other Fundumenentals of CeriBell
CeriBell Net Income component correlations
CeriBell Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for CeriBell is extremely important. It helps to project a fair market value of CeriBell Stock properly, considering its historical fundamentals such as Net Income. Since CeriBell's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CeriBell's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CeriBell's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell. If investors know CeriBell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CeriBell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.67) | Revenue Per Share | Quarterly Revenue Growth 0.314 | Return On Assets | Return On Equity |
The market value of CeriBell is measured differently than its book value, which is the value of CeriBell that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell's value that differs from its market value or its book value, called intrinsic value, which is CeriBell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell's market value can be influenced by many factors that don't directly affect CeriBell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CeriBell's value and its price as these two are different measures arrived at by different means. Investors typically determine if CeriBell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CeriBell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CeriBell 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CeriBell's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CeriBell.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in CeriBell on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding CeriBell or generate 0.0% return on investment in CeriBell over 90 days. CeriBell is related to or competes with Treace Medical, Orthopediatrics Corp, Standard Biotools, Enhabit, QuantumSi, Varex Imaging, and Butterfly Network. CeriBell is entity of United States. It is traded as Stock on NASDAQ exchange. More
CeriBell Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CeriBell's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CeriBell upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.76 | |||
| Information Ratio | 0.2457 | |||
| Maximum Drawdown | 16.78 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 7.04 |
CeriBell Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for CeriBell's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CeriBell's standard deviation. In reality, there are many statistical measures that can use CeriBell historical prices to predict the future CeriBell's volatility.| Risk Adjusted Performance | 0.2041 | |||
| Jensen Alpha | 0.8343 | |||
| Total Risk Alpha | 0.6032 | |||
| Sortino Ratio | 0.3131 | |||
| Treynor Ratio | 0.6574 |
CeriBell January 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.2041 | |||
| Market Risk Adjusted Performance | 0.6674 | |||
| Mean Deviation | 2.68 | |||
| Semi Deviation | 2.14 | |||
| Downside Deviation | 2.76 | |||
| Coefficient Of Variation | 373.16 | |||
| Standard Deviation | 3.51 | |||
| Variance | 12.33 | |||
| Information Ratio | 0.2457 | |||
| Jensen Alpha | 0.8343 | |||
| Total Risk Alpha | 0.6032 | |||
| Sortino Ratio | 0.3131 | |||
| Treynor Ratio | 0.6574 | |||
| Maximum Drawdown | 16.78 | |||
| Value At Risk | (3.94) | |||
| Potential Upside | 7.04 | |||
| Downside Variance | 7.59 | |||
| Semi Variance | 4.57 | |||
| Expected Short fall | (3.22) | |||
| Skewness | 0.5815 | |||
| Kurtosis | 0.6199 |
CeriBell Backtested Returns
CeriBell appears to be not too volatile, given 3 months investment horizon. CeriBell secures Sharpe Ratio (or Efficiency) of 0.27, which signifies that the company had a 0.27 % return per unit of risk over the last 3 months. By analyzing CeriBell's technical indicators, you can evaluate if the expected return of 0.96% is justified by implied risk. Please makes use of CeriBell's Mean Deviation of 2.68, risk adjusted performance of 0.2041, and Downside Deviation of 2.76 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, CeriBell holds a performance score of 21. The firm shows a Beta (market volatility) of 1.42, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, CeriBell will likely underperform. Please check CeriBell's downside variance, and the relationship between the treynor ratio and kurtosis , to make a quick decision on whether CeriBell's price patterns will revert.
Auto-correlation | 0.60 |
Good predictability
CeriBell has good predictability. Overlapping area represents the amount of predictability between CeriBell time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CeriBell price movement. The serial correlation of 0.6 indicates that roughly 60.0% of current CeriBell price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.6 | |
| Spearman Rank Test | 0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 0.69 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, CeriBell reported net income of (40.45 Million). This is 111.85% lower than that of the Health Care Equipment & Supplies sector and 116.99% lower than that of the Health Care industry. The net income for all United States stocks is 107.09% higher than that of the company.
CeriBell Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CeriBell's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CeriBell could also be used in its relative valuation, which is a method of valuing CeriBell by comparing valuation metrics of similar companies.CeriBell is currently under evaluation in net income category among its peers.
CeriBell ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CeriBell's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CeriBell's managers, analysts, and investors.Environmental | Governance | Social |
CeriBell Fundamentals
| Return On Equity | -0.6 | ||||
| Return On Asset | -0.29 | ||||
| Profit Margin | (0.63) % | ||||
| Operating Margin | (0.65) % | ||||
| Current Valuation | 694.13 M | ||||
| Shares Outstanding | 37.1 M | ||||
| Shares Owned By Insiders | 10.51 % | ||||
| Shares Owned By Institutions | 81.64 % | ||||
| Number Of Shares Shorted | 1.55 M | ||||
| Price To Book | 5.13 X | ||||
| Price To Sales | 10.16 X | ||||
| Revenue | 65.44 M | ||||
| Gross Profit | 72.87 M | ||||
| EBITDA | (37.32 M) | ||||
| Net Income | (40.45 M) | ||||
| Total Debt | 21.96 M | ||||
| Book Value Per Share | 4.43 X | ||||
| Cash Flow From Operations | (35.04 M) | ||||
| Short Ratio | 2.68 X | ||||
| Earnings Per Share | (3.67) X | ||||
| Target Price | 28.14 | ||||
| Number Of Employees | 281 | ||||
| Market Capitalization | 841.7 M | ||||
| Total Asset | 225.41 M | ||||
| Retained Earnings | (166.94 M) | ||||
| Working Capital | 204.28 M | ||||
| Net Asset | 225.41 M |
About CeriBell Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CeriBell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CeriBell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CeriBell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out CeriBell Piotroski F Score and CeriBell Altman Z Score analysis. For more information on how to buy CeriBell Stock please use our How to buy in CeriBell Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell. If investors know CeriBell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CeriBell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.67) | Revenue Per Share | Quarterly Revenue Growth 0.314 | Return On Assets | Return On Equity |
The market value of CeriBell is measured differently than its book value, which is the value of CeriBell that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell's value that differs from its market value or its book value, called intrinsic value, which is CeriBell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell's market value can be influenced by many factors that don't directly affect CeriBell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CeriBell's value and its price as these two are different measures arrived at by different means. Investors typically determine if CeriBell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CeriBell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.